CCDRD AG has extensive experience with generic Tiotropium product development compared to the reference product Spiriva®.

• 20 pilot and pivotal trials performed with Tiotropium inhalers in healthy subjects
• systemic safety and pulmonary deposition studies
• highly experienced investigators and study teams in the phase I units available
• standardized training and clinical procedures
• intrasubject and residual variance data available
• information about product aging available